Alembic Pharma gets tentative USFDA nod for breast cancer drug

The medicine is indicated for the treatment of adult patients with a certain type of advanced or metastatic breast cancer in a combination of drug therapy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u6KXnL8
via IFTTT